The clinical literature has reported that the majority of free flap complications occur within 48 hours post operatively. ViOptix’s T.Ox system allows unprecedented, anytime/anywhere non-invasive monitoring of oxygen saturation in targeted tissues following surgery. As the company’s first product it has secured the market leadership position in breast flap reconstructions.